{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:18:33Z","timestamp":1761059913637},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiolog\u00eda"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.rx.2015.01.008","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T18:06:25Z","timestamp":1428429985000},"page":"496-504","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Quimioembolizaci\u00f3n transarterial con part\u00edculas liberadoras de doxorrubicina frente a quimioembolizaci\u00f3n transarterial convencional en carcinomas hepatocelulares irresecables: un estudio de eficacia, seguridad y gastos"],"prefix":"10.1016","volume":"57","author":[{"given":"J.E.","family":"Meg\u00edas Vericat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Garc\u00eda Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"L\u00f3pez Briz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"G\u00f3mez Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ramos Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Mart\u00ednez Rodrigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Poveda Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rx.2015.01.008_bib0185","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/gut.2004.048124","article-title":"Prognostic factors for survival in patients with early intermediate hepatocellular carcinoma undergoing nonsurgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre","volume":"54","author":"Grieco","year":"2005","journal-title":"Gut."},{"key":"10.1016\/j.rx.2015.01.008_bib0190","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"Llovet","year":"2012","journal-title":"J Hepatol."},{"key":"10.1016\/j.rx.2015.01.008_bib0195","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet."},{"key":"10.1016\/j.rx.2015.01.008_bib0200","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology."},{"key":"10.1016\/j.rx.2015.01.008_bib0205","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology."},{"key":"10.1016\/j.rx.2015.01.008_bib0210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","article-title":"Transarterial therapy for hepatocellular carcinoma: which technique is more effective?. A systematic review of cohort and randomized studies","volume":"30","author":"Marelli","year":"2007","journal-title":"Cardiovasc Intervent Radiol."},{"key":"10.1016\/j.rx.2015.01.008_bib0215","first-page":"CD004787","article-title":"Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma","volume":"16","author":"Oliveri","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.rx.2015.01.008_bib0220","doi-asserted-by":"crossref","unstructured":"Groupe d\u2019Etude et de Traitement du Carcinome H\u00e9patocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 1995;332:1256-61.","DOI":"10.1056\/NEJM199505113321903"},{"key":"10.1016\/j.rx.2015.01.008_bib0225","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(98)80187-6","article-title":"Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial, Groupe CHC","volume":"29","author":"Pelletier","year":"1998","journal-title":"J Hepatol."},{"key":"10.1016\/j.rx.2015.01.008_bib0230","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejca.2008.01.004","article-title":"Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive 9402)","volume":"44","author":"Doffo\u00ebl","year":"2008","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.rx.2015.01.008_bib0235","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep.510270617","article-title":"Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution","volume":"27","author":"Bruix","year":"1998","journal-title":"Hepatology."},{"key":"10.1016\/j.rx.2015.01.008_bib0240","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00270-007-9226-z","article-title":"Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients","volume":"31","author":"Malagari","year":"2008","journal-title":"Cardiovasc Intervent Radiol."},{"key":"10.1016\/j.rx.2015.01.008_bib0245","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/PPO.0b013e3181c5214b","article-title":"Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States","volume":"15","author":"Reyes","year":"2009","journal-title":"Cancer J."},{"key":"10.1016\/j.rx.2015.01.008_bib0250","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00270-008-9409-2","article-title":"Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study","volume":"31","author":"Grosso","year":"2008","journal-title":"Cardiovasc Intervent Radiol."},{"key":"10.1016\/j.rx.2015.01.008_bib0255","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00270-009-9750-0","article-title":"Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma","volume":"33","author":"Malagari","year":"2010","journal-title":"Cardiovasc Intervent Radiol."},{"key":"10.1016\/j.rx.2015.01.008_bib0260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol."},{"key":"10.1016\/j.rx.2015.01.008_bib0265","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jso.21522","article-title":"Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)","volume":"101","author":"Dhanasekaran","year":"2010","journal-title":"J Surg Oncol."},{"key":"10.1016\/j.rx.2015.01.008_bib0270","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2011.07.010","article-title":"Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: a multi-institutional registry","volume":"213","author":"Martin","year":"2011","journal-title":"J Am Coll Surg."},{"key":"10.1016\/j.rx.2015.01.008_bib0275","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.farma.2010.06.006","article-title":"Experiencia de uso de part\u00edculas DC Bead\u00ae cargadas con doxorrubicina en quimioembolizaci\u00f3n hep\u00e1tica","volume":"35","author":"Muros-Ortega","year":"2011","journal-title":"Farm Hosp."},{"key":"10.1016\/j.rx.2015.01.008_bib0280","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.rx.2010.05.008","article-title":"Treatment of hepatocellular carcinoma using precision transcatheter arterial chemoembolization (TACE): results of two years\u2019 experience in a general hospital","volume":"52","author":"Garc\u00eda-Hidalgo Alonso","year":"2010","journal-title":"Radiologia."},{"key":"10.1016\/j.rx.2015.01.008_bib0285","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jhep.2012.01.008","article-title":"Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design","volume":"56","author":"Burrel","year":"2012","journal-title":"J Hepatol."},{"key":"10.1016\/j.rx.2015.01.008_bib0290","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00270-012-0394-0","article-title":"Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis","volume":"35","author":"Malagari","year":"2012","journal-title":"Cardiovasc Intervent Radiol."},{"key":"10.1016\/j.rx.2015.01.008_bib0295","doi-asserted-by":"crossref","first-page":"CR189","DOI":"10.12659\/MSM.881714","article-title":"Transarterial chemoembolization of Child-A hepatocellular carcinoma: drug-eluting bead TACE (DEB TACE) vs. TACE with cisplatin\/lipiodol (cTACE)","volume":"17","author":"Wiggermann","year":"2011","journal-title":"Med Sci Monit."},{"key":"10.1016\/j.rx.2015.01.008_bib0300","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jvir.2011.07.002","article-title":"Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma","volume":"22","author":"Sacco","year":"2011","journal-title":"J Vasc Interv Radiol."},{"key":"10.1016\/j.rx.2015.01.008_bib0305","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000329602","article-title":"A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma","volume":"34","author":"van Malenstein","year":"2011","journal-title":"Onkologie."},{"key":"10.1016\/j.rx.2015.01.008_bib0310","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jhep.2012.07.017","article-title":"Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma","volume":"57","author":"Song","year":"2012","journal-title":"J Hepatol."},{"key":"10.1016\/j.rx.2015.01.008_bib0315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.diii.2012.05.001","article-title":"Result and cost of hepatic chemoembolisation with drug eluting beads in 21 patients","volume":"94","author":"Vadot","year":"2013","journal-title":"Diagn Interv Imaging."},{"key":"10.1016\/j.rx.2015.01.008_bib0320","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1684\/bdc.2011.1370","article-title":"Economic impact of transarterial chemoembolization with drug eluting beads in the treatment of hepatocellular carcinoma","volume":"98","author":"Malbranche","year":"2011","journal-title":"Bull Cancer."},{"key":"10.1016\/j.rx.2015.01.008_bib0325","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.diii.2013.10.012","article-title":"Medico-economic study of the management of hepatocellular carcinoma by chemo-embolization","volume":"95","author":"Clouet","year":"2014","journal-title":"Diagn Interv Imaging."},{"key":"10.1016\/j.rx.2015.01.008_bib0330","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jcpt.12230","article-title":"Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinoma","volume":"40","author":"Vadot","year":"2015","journal-title":"J Clin Pharm Ther."},{"key":"10.1016\/j.rx.2015.01.008_bib0335","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.rx.2010.07.010","article-title":"Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma","volume":"53","author":"Ferrer Puchol","year":"2011","journal-title":"Radiologia."},{"key":"10.1016\/j.rx.2015.01.008_bib0340","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.RVI.0000196277.76812.A3","article-title":"Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies","volume":"17","author":"Brown","year":"2006","journal-title":"J Vasc Interv Radiol."},{"key":"10.1016\/j.rx.2015.01.008_bib0345","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2009.27.15_suppl.4524","article-title":"Drug eluting beads versus conventional TACE for unresectable hepatocellular carcinoma: Survival benefits and safety","volume":"27","author":"Dhanasekaran","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rx.2015.01.008_bib0350","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jvir.2008.02.018","article-title":"Three-dimensional C-arm cone-beam CT: applications in the interventional suite","volume":"19","author":"Wallace","year":"2008","journal-title":"J Vasc Interv Radiol."},{"key":"10.1016\/j.rx.2015.01.008_bib0355","unstructured":"Red Espa\u00f1ola de Farmacoepidemiolog\u00eda. EPIMED 2010. Medicamentos y casu\u00edstica en hospitales espa\u00f1oles. Badalona (Barcelona): Euromedicine; 2011."},{"key":"10.1016\/j.rx.2015.01.008_bib0360","unstructured":"Bolet\u00edn Oficial del Estado Actualizaci\u00f3n de los anexos I, II y III del RD 1207\/2006 que regula la gesti\u00f3n del Fondo de Cohesi\u00f3n Sanitaria. BOE-A-2012-15243, 2012; 303: 85925."}],"container-title":["Radiolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033833815000764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033833815000764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T15:34:38Z","timestamp":1598888078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033833815000764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0033833815000764"],"URL":"https:\/\/doi.org\/10.1016\/j.rx.2015.01.008","relation":{},"ISSN":["0033-8338"],"issn-type":[{"value":"0033-8338","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quimioembolizaci\u00f3n transarterial con part\u00edculas liberadoras de doxorrubicina frente a quimioembolizaci\u00f3n transarterial convencional en carcinomas hepatocelulares irresecables: un estudio de eficacia, seguridad y gastos","name":"articletitle","label":"Article Title"},{"value":"Radiolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rx.2015.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 SERAM. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}